99 related articles for article (PubMed ID: 29138025)
1. Novel all-hydrocarbon stapled p110α[E545K] peptides as blockers of the oncogenic p110α[E545K]-IRS1 interaction.
Hu X; He Y; Wu L; Hao Y; Wang Z; Zheng W
Bioorg Med Chem Lett; 2017 Dec; 27(24):5446-5449. PubMed ID: 29138025
[TBL] [Abstract][Full Text] [Related]
2. Gain of interaction with IRS1 by p110α-helical domain mutants is crucial for their oncogenic functions.
Hao Y; Wang C; Cao B; Hirsch BM; Song J; Markowitz SD; Ewing RM; Sedwick D; Liu L; Zheng W; Wang Z
Cancer Cell; 2013 May; 23(5):583-93. PubMed ID: 23643389
[TBL] [Abstract][Full Text] [Related]
3. Bis-Lactam Peptide [
Wu B; Zheng W
Molecules; 2020 Oct; 25(19):. PubMed ID: 33019638
[TBL] [Abstract][Full Text] [Related]
4. p110α Hot Spot Mutations E545K and H1047R Exert Metabolic Reprogramming Independently of p110α Kinase Activity.
Chaudhari A; Krumlinde D; Lundqvist A; Akyürek LM; Bandaru S; Skålén K; Ståhlman M; Borén J; Wettergren Y; Ejeskär K; Rotter Sopasakis V
Mol Cell Biol; 2015 Oct; 35(19):3258-73. PubMed ID: 26169833
[TBL] [Abstract][Full Text] [Related]
5. The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR.
Zhao S; Cao Y; Liu SB; Wang XA; Bao RF; Shu YJ; Hu YP; Zhang YJ; Jiang L; Zhang F; Liang HB; Li HF; Ma Q; Xu Y; Wang Z; Zhang YC; Chen L; Zhou J; Liu YB
J Exp Clin Cancer Res; 2016 Jun; 35(1):97. PubMed ID: 27317099
[TBL] [Abstract][Full Text] [Related]
6. Assessing the subcellular distribution of oncogenic phosphoinositide 3-kinase using microinjection into live cells.
Layton MJ; Rynkiewicz NK; Ivetac I; Horan KA; Mitchell CA; Phillips WA
Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919038
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells.
Arjumand W; Merry CD; Wang C; Saba E; McIntyre JB; Fang S; Kornaga E; Ghatage P; Doll CM; Lees-Miller SP
Oncotarget; 2016 Dec; 7(50):82424-82439. PubMed ID: 27489350
[TBL] [Abstract][Full Text] [Related]
8. Insights into the mechanism of the PIK3CA E545K activating mutation using MD simulations.
Leontiadou H; Galdadas I; Athanasiou C; Cournia Z
Sci Rep; 2018 Oct; 8(1):15544. PubMed ID: 30341384
[TBL] [Abstract][Full Text] [Related]
9. Targeting the protein-protein interaction between IRS1 and mutant p110α for cancer therapy.
Hao Y; Zhao S; Wang Z
Toxicol Pathol; 2014 Jan; 42(1):140-7. PubMed ID: 24178578
[TBL] [Abstract][Full Text] [Related]
10. Sam domain-based stapled peptides: Structural analysis and interaction studies with the Sam domains from the EphA2 receptor and the lipid phosphatase Ship2.
Mercurio FA; Pirone L; Di Natale C; Marasco D; Pedone EM; Leone M
Bioorg Chem; 2018 Oct; 80():602-610. PubMed ID: 30036816
[TBL] [Abstract][Full Text] [Related]
11. The reciprocal stability of FOXO1 and IRS2 creates a regulatory circuit that controls insulin signaling.
Guo S; Dunn SL; White MF
Mol Endocrinol; 2006 Dec; 20(12):3389-99. PubMed ID: 16916938
[TBL] [Abstract][Full Text] [Related]
12. The oncogenic properties of mutant p110alpha and p110beta phosphatidylinositol 3-kinases in human mammary epithelial cells.
Zhao JJ; Liu Z; Wang L; Shin E; Loda MF; Roberts TM
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18443-8. PubMed ID: 16339315
[TBL] [Abstract][Full Text] [Related]
13. Effects of oncogenic p110alpha subunit mutations on the lipid kinase activity of phosphoinositide 3-kinase.
Carson JD; Van Aller G; Lehr R; Sinnamon RH; Kirkpatrick RB; Auger KR; Dhanak D; Copeland RA; Gontarek RR; Tummino PJ; Luo L
Biochem J; 2008 Jan; 409(2):519-24. PubMed ID: 17877460
[TBL] [Abstract][Full Text] [Related]
14. Stereochemical effects of all-hydrocarbon tethers in i,i+4 stapled peptides.
Kim YW; Verdine GL
Bioorg Med Chem Lett; 2009 May; 19(9):2533-6. PubMed ID: 19332370
[TBL] [Abstract][Full Text] [Related]
15. Long-term p110α PI3K inactivation exerts a beneficial effect on metabolism.
Foukas LC; Bilanges B; Bettedi L; Pearce W; Ali K; Sancho S; Withers DJ; Vanhaesebroeck B
EMBO Mol Med; 2013 Apr; 5(4):563-71. PubMed ID: 23483710
[TBL] [Abstract][Full Text] [Related]
16. Targeting of β-Catenin Reverses Radioresistance of Cervical Cancer with the
Jiang W; Wu Y; He T; Zhu H; Ke G; Xiang L; Yang H
Mol Cancer Ther; 2020 Feb; 19(2):337-347. PubMed ID: 31666350
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of insulin receptor substrate 1 reduces proliferation and downregulates Akt/mTOR and MAPK pathways in K562 cells.
Machado-Neto JA; Favaro P; Lazarini M; Costa FF; Olalla Saad ST; Traina F
Biochim Biophys Acta; 2011 Aug; 1813(8):1404-11. PubMed ID: 21569802
[TBL] [Abstract][Full Text] [Related]
18. RAS interaction with PI3K p110α is required for tumor-induced angiogenesis.
Murillo MM; Zelenay S; Nye E; Castellano E; Lassailly F; Stamp G; Downward J
J Clin Invest; 2014 Aug; 124(8):3601-11. PubMed ID: 25003191
[TBL] [Abstract][Full Text] [Related]
19. The Phosphoinosotide 3-Kinase Catalytic Subunit p110α is Required for Normal Lens Growth.
Sellitto C; Li L; Vaghefi E; Donaldson PJ; Lin RZ; White TW
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3145-51. PubMed ID: 27304846
[TBL] [Abstract][Full Text] [Related]
20. HC toxin (a HDAC inhibitor) enhances IRS1-Akt signalling and metabolism in mouse myotubes.
Tan HW; Sim AY; Huang SL; Leng Y; Long YC
J Mol Endocrinol; 2015 Dec; 55(3):197-207. PubMed ID: 26373795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
